Health Care & Life Sciences » Pharmaceuticals | Hainan Honz Pharmaceutical Co. Ltd.

Hainan Honz Pharmaceutical Co. Ltd. | Income Statement

Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
305,717.90
403,143.20
405,926.60
465,473.80
472,437.70
869,925.10
Cost of Goods Sold (COGS) incl. D&A
186,944.20
225,875.00
241,444.60
297,734.60
298,547.70
520,315.70
Gross Income
118,773.80
177,268.10
164,482.00
167,739.30
173,890.00
349,609.40
SG&A Expense
112,666.20
121,656.40
106,420.60
128,298.80
129,204.30
308,861.80
EBIT
628.00
45,017.40
-
34,897.60
40,701.90
35,539.10
Unusual Expense
5,944.70
8,782.70
8,012.70
15,355.00
8,631.30
10,705.60
Non Operating Income/Expense
535.20
7,754.50
2,333.10
891.00
17,470.20
18,719.40
Interest Expense
-
212.90
1,255.70
4,582.30
3,534.40
10,411.60
Pretax Income
29,267.70
78,976.70
86,410.80
50,360.20
64,765.40
35,516.10
Income Tax
14,840.70
20,377.80
19,535.90
10,209.90
14,331.90
13,123.80
Equity in Affiliates
-
-
-
1,472.60
2,399.30
1,372.40
Consolidated Net Income
14,426.90
58,598.90
66,874.90
38,677.70
48,034.20
21,019.90
Net Income
14,852.90
59,081.70
68,197.20
46,156.60
50,196.90
13,366.20
Net Income After Extraordinaries
14,852.90
59,081.70
68,197.20
46,156.60
50,196.90
13,366.20
Net Income Available to Common
14,852.90
59,081.70
68,197.20
46,156.60
50,196.90
13,366.20
EPS (Basic)
0.03
0.13
0.15
0.10
0.11
0.03
Basic Shares Outstanding
450,000.90
450,000.50
450,000.00
450,000.00
450,000.00
450,000
EPS (Diluted)
0.03
0.13
0.15
0.10
0.11
0.03
Diluted Shares Outstanding
450,000.90
450,000.50
450,000.00
450,000.00
450,000.00
450,000
EBITDA
40,892.40
93,156.80
103,578.80
77,359.20
84,203.20
96,047.70
Other Operating Expense
6,735.60
10,594.30
8,120.90
4,542.90
3,983.80
5,208.60
Non-Operating Interest Income
30,000.90
30,089.30
38,807.10
35,702.90
1,496.40
2,374.90
Minority Interest Expense
426.00
482.80
1,322.30
7,478.90
2,162.70
7,653.70

About Hainan Honz Pharmaceutical Co.

View Profile
Address
No. 6 Yaogu Third Road
Haikou Hainan 570311
China
Employees -
Website http://www.honz.com.cn
Updated 07/08/2019
Honz Pharmaceutical Co., Ltd. engages in the manufacture and distribution of drugs for children. It offers western medicines and Chinese patent drugs, including antipyretic and analgesic drugs, cold drugs, antibiotics drugs, respiratory system drugs, digestant, and arresting convulsion drugs. Its products include nimesulide granules, cefminox sodium for injection, zhike juhong granules, ganmao qingre granules, artificial cow-bezoar and chlorphenamine maleate granules, cefaclor granules, carbocisteine granules, jianerle granules, pediatric vitamins, calcium gluconate granules, ribavirin pellets, and Norfloxacin capsules for adults.